Meningitis A in Burkina Faso

By Moderator in Global initiatives 810 views 26th January 2018 Video Duration: 00:03:15
MenAfriVac, a new vaccine against Meningococcal Meningitis seroptype Nm A, is expected to prevent meningitis epidemics in Africa's "meningitis belt" of 25 countries that stretch from Senegal in the west to Ethiopia in the east. Hit by epidemics every few years, the meningitis belt accounts for 95 percent of the world's meningococcal meningitis disease burden. The region's worst epidemic in recent times, the 1996 epidemic, hit more than 250,000 people in the region, killing 25,000 people and causing residual disability for 50,000 others. Besides the death and disability though, meningitis epidemics have a profound socio-political significance too. Epidemics frighten people away from work and cost large amounts of money to handle. Developed by the Meningitis Vaccine Project, a joint project of PATH and WHO, the vaccine was launched in Burkina Faso in November 2010. MenAfriVac costs less than 50 US cents per dose and is 95 percent effective. The GAVI Alliance is paying the overwhelming majority of costs to roll the vaccine out. If fully funded, GAVI expects to see 236 million people vaccinated with MenAfriVac in all 25 countries of the meningitis belt.

People In This Video
No users are tagged in this video

0
0
0
0
0
0

Other Videos

00:57:27
This TechNet-21 webinar on vaccine vial monitor (VVM)-based vaccine management was given on the occasion of the...
This TechNet-21 webinar on vaccine vial monitor (VVM)-based vaccine management was given on the occasion of the publishing of “The Book of VVM: Yesterday-today-and-tomorrow” by Umit Kartoglu. During this webinar, the presenters discussed the critical role of VVM in vaccine management policies as well as the VVM shaping the future of the (digitized) cold chain. The presenters were:

- Umit Kartoglu, Co-founder and CEO, Extensio et Progressio, Collonge-Bellerive, Switzerland (author of The Book of VVM)
- Debbie Kristensen, Director of Vaccine Technology, Strategy, and Policy / Medical Devices and Health Technologies, PATH, Geneva, Switzerland
- Ted Prusik, Co-founder and Senior Vice President, Temptime Corporation, Morris Plains, NJ, USA
More
00:47:09
Five proven strategies to improve immunization data use (Findings from the Immunization Data: Evidence for Action...
Five proven strategies to improve immunization data use (Findings from the Immunization Data: Evidence for Action Review) - A TechNet Webinar with PATH - IDEA
More
01:33:12
Joint webinar with UPDWG and TechNet-21 featuring UNICEF and VillageReach.
00:48:58
On this episode of StarTalk Radio, Neil deGrasse Tyson sits down with first-time comic co-host Felicia Madison and...
On this episode of StarTalk Radio, Neil deGrasse Tyson sits down with first-time comic co-host Felicia Madison and returning friend of the show and Pulitzer ...
More
00:55:53
This webinar describes how to use the TechNet-21 cold chain equipment (CCE) area and provides un update on the new...
This webinar describes how to use the TechNet-21 cold chain equipment (CCE) area and provides un update on the new WHO PQS website which is under construction.
More
Unable to load tooltip content.